Argenica Therapeutics (ASX: AGN) prepares for phase one trial of neuroprotective drug (w/ Liz Dallimore)

Small Caps - A podcast by Small Caps

Argenica Therapeutics (ASX: AGN) chief executive officer Dr Liz Dallimore joins Small Caps to discuss the development pathway of the...